A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...
Opinions expressed by Forbes Contributors are their own. A.J. Herrington is freelance writer covering weed news and culture. A California biopharmaceutical company has announced positive results ...
It's impossible to predict how MDMA affects users even with on-site testing at festivals, researchers are warning. More than 650 seized ecstasy tablets were tested in a study by Queen Mary ...
There’s been a lot of news recently about the use of MDMA, sometimes known as ecstasy or molly, combined with psychotherapy, as a novel treatment for trauma. Partly, the news has been good.
Lykos accepts FDA’s view that reviving rejected MDMA therapy’s fortunes requires fresh phase 3 trial
Lykos Therapeutics may have shed three-quarters of its staff in the wake of the FDA's rejection of its MDMA candidate for post-traumatic stress disorder, but the biotech’s new leadership ...
The assumption was that whatever the risks of legalizing therapeutic MDMA, the crisis of PTSD gripping the country (and doing nothing about it) would be considered the larger risk. That was not ...
Cannabis is increasingly being smuggled into Japan in liquid form, according to Tokyo ... followed by cannabis (69 kg), MDMA (13 kg) and cocaine (9 kg). Separately, 21,000 tablets of MDMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback